Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro can cause wind. Flatulence, bloating and burping are among the gastrointestinal side effects listed in the medicine's official prescribing information, and they appear in clinical trial data too. They tend to be most noticeable in the first few weeks of treatment or after a dose increase, and for most people they settle down as the body adjusts. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works by activating two gut-hormone receptors, GIP and GLP-1, which together reduce appetite and slow the rate at which food leaves your stomach. That slowing (called delayed gastric emptying) is central to how the medicine helps you feel full for longer. It also means food spends more time fermenting in the digestive tract, which is the direct cause of increased wind for many people.
Because digestion is running at a slower pace, gas that would normally move through more quickly can build up. The result is flatulence, bloating, burping, or some combination of the three. This is not a sign that something has gone wrong; it reflects the medicine doing precisely what it is designed to do. The NHS patient information for tirzepatide lists these effects alongside nausea, diarrhoea and constipation as common gastrointestinal reactions. If you want to understand the broader side-effect picture, the Mounjaro overview on our site covers what to expect across the treatment journey.
Worth knowing: the effect is dose-related to a degree. Starting at 2.5mg is specifically designed to let your system adapt before the dose increases. If you are curious about whether Mounjaro gives you wind and why that happens, the picture becomes clearer when you understand how gastric slowing compounds over successive dose steps. Wind and bloating that feel manageable at 2.5mg may return briefly each time the dose steps up, that pattern is predictable and usually short-lived.
Most people notice gastrointestinal symptoms, including wind, most acutely in the first one to two weeks after starting Mounjaro or after moving to a higher dose. The prescribing information and clinical trial data consistently show that these effects are most common early and tend to diminish as the body acclimates to the new level of gastric slowing.
In the SURMOUNT-1 trial (which followed thousands of adults over 72 weeks) gastrointestinal side effects were the most frequently reported category, but the majority were rated mild to moderate in severity. Discontinuation specifically because of GI effects was relatively uncommon. The data are published in the New England Journal of Medicine for anyone who wants the granular breakdown.
If you have questions about an unusual pattern (wind accompanied by severe stomach pain that radiates to the back, for instance) that warrants prompt medical attention rather than watchful waiting. Severe, persistent abdominal pain is a symptom the MHRA specifically flags in relation to GLP-1 medicines. You can also read more about wind pain specifically to understand when discomfort crosses a threshold worth escalating.
There is no single fix, but several evidence-informed adjustments consistently help. Eating more slowly reduces the volume of air swallowed with food, which directly cuts the amount available to escape later. Smaller, more frequent meals put less pressure on a stomach that is already emptying at a reduced pace.
Carbonated drinks are worth reconsidering. Fizzy water, sparkling mixers and sodas all introduce gas before food even reaches your stomach; cutting them, at least during the period when your dose has recently increased, takes away one straightforward source. High-fat meals slow gastric emptying further on top of Mounjaro's own effect, so reducing very fatty or fried foods during the adaptation phase is consistently the advice given by clinical teams.
Some people find that keeping a rough food diary for a fortnight after a dose change helps them identify which specific foods correlate with their worst days. It is a low-effort way to personalise what is otherwise quite general guidance. Our FAQs section includes questions about managing day-to-day life on treatment if you want a broader view. And if you are weighing up the overall cost and structure of private treatment, the Mounjaro cost page sets out what a private prescription actually includes.
Wind that is uncomfortable but manageable does not usually require a clinical call. Mounjaro wind that is severe enough to affect your sleep, social life or work, or that is accompanied by significant bloating, cramping, or a change in your bowel pattern that does not ease after two to three weeks, is worth raising, and your prescriber may suggest a slower titration schedule, review your current dose, or recommend additional support.
A small number of people find that wind and bloating persist beyond the usual adaptation window. That is a real and valid experience, and it is exactly the kind of thing that should go to a prescriber rather than being quietly tolerated. At nume, aftercare is available seven days a week, your prescriber reviews every repeat order before it is dispensed, so there is a natural checkpoint built into the process.
It is also worth remembering that Mounjaro can affect more than digestion, and people who want to know whether Mounjaro can make periods worse will find that hormonal and cycle changes are another area worth discussing with a prescriber. Questions about whether to continue, change dose or switch treatment are clinical decisions, not ones to make based on a forum thread. If something does not feel right, get in touch with our clinical team. You can also report any suspected side effects directly to the MHRA via the Yellow Card scheme.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.